Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Glasses designed to block blue light improve sleep and ADHD symptoms

Scientists at John Carroll University, working in its Lighting Innovations Institute, have developed an affordable accessory that appears to reduce the symptoms of ADHD. Their discovery also has also been shown to improve sleep patterns among people who have difficulty falling asleep.

13 Nov 2007

Cortex maturation in attention deficit hyperactivity disorder

In youth with attention deficit hyperactivity disorder (ADHD), the brain matures in a normal pattern but is delayed three years in some regions, on average, compared to youth without the disorder, an imaging study by researchers at the National Institutes of Health's (NIH) National Institute of Mental Health (NIMH) has revealed.

13 Nov 2007

Overweight mothers run greater risk of having hyperactive children

If a woman is overweight when she becomes pregnant, the probability is much greater that her child will evince ADHD-like symptoms when he/she reaches school age, according to a new Nordic study.

5 Nov 2007

Barr confirms patent challenge of Ritalin LA

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Novartis Pharmaceuticals Corporation in connection with its Ritalin LA (methylphenidate hydrochloride) extended-release capsules, 10mg, 20mg, 30mg and 40mg.

5 Nov 2007

Overweight mothers run greater risk of having hyperactive children

If a woman is overweight when she becomes pregnant, the probability is much greater that her child will evince ADHD-like symptoms when he/she reaches school age, according to a new Nordic study.

2 Nov 2007

Shire announces data from a 12-month study of Daytrana for ADHD

Shire plc has announced that data from a 12-month study of DAYTRANATM (methylphenidate transdermal system), the Attention Deficit Hyperactivity Disorder (ADHD) patch, demonstrated that DAYTRANA provided significant ADHD tolerability and symptom control improvement in children aged 6 to 12 years.

28 Oct 2007

Psychiatrists, parents significantly differ in ADHD, psychiatric comorbidities perceptions

According to a small-scale, in-office, observational study, psychiatrists and parents have significantly different perceptions of the importance of pediatric ADHD and psychiatric comorbidities, particularly regarding the patients' most concerning behavior.

25 Oct 2007

MSU researcher helps develop computer game for Ugandan children recovering from cerebral malaria

The computer program Captain's Log - originally used with individuals diagnosed with attention deficit hyperactivity disorder, brain injuries or learning disabilities - is being adapted to rehabilitate Ugandan children who are survivors of cerebral malaria.

24 Oct 2007

Dads often missing from their child's ADHD treatment program

While working with parents of children with attention deficit hyperactivity disorder (ADHD) at the University at Buffalo, Gregory A. Fabiano noticed something was missing: the fathers.

24 Oct 2007

Identifying psychiatric and behavioral problems in teens

Your teen is moody. He's not doing well in school. He wants to be left alone. Does he have a learning disability? Depression? Or maybe he's just a normal teen?

19 Oct 2007

Insulin levels affect the brain's dopamine systems

Insulin, long known as an important regulator of blood glucose levels, now has a newly appreciated role in the brain.

18 Oct 2007

Tonsillectomy sorts out children's sleep apnea and improves their behaviour

Doctors in the U.S. say children diagnosed with sleep-related breathing disorders sleep better after their tonsils and adenoids are removed.

17 Oct 2007

Removal of tonsils and adenoids improves sleep and behavior in children with breathing disorders

Children diagnosed with sleep-disordered breathing appear to sleep better and have improved behavior following removal of their tonsils and adenoids, according to a report in the October issue of Archives of Otolaryngology-Head & Neck Surgery.

16 Oct 2007

New analyses of long-term LIALDA (mesalamine) data presented at ACG

Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis.

16 Oct 2007

Improving working memory by computerized strategy in ADHD

Attention-deficit/hyperactivity disorder (ADHD), a state of serious impairments in both learning ability and social functioning, is one of many labels for one of the most prevalent conditions in child psychiatry, and, undoubtedly, the most controversial, which partly persists into adulthood.

15 Oct 2007

Wal-Mart adds 11 generic drugs to discounted prescription drug program

Wal-Mart Stores on Thursday announced that it will begin selling eight additional generic drugs for $4 per 30-day prescription and several family-planning drugs for $9, USA Today reports (Appleby, USA Today, 9/28).

2 Oct 2007

Genetics and learning

New research is giving scientists fresh insights into how genetics are a prime factor in how we learn.

2 Oct 2007

Calls for ban on food additives in Britain

The Food Standards Agency (FSA), which is the UK's food watchdog has promised the public that it will clarify it's advice on food additives.

24 Sep 2007

Top five prescribed drugs

With a total nearly $5 billion, Lipitor, a cholesterol-reducing drug, ranked first in terms of total spending on prescription medicines by adults ages 18 to 64 in 2004, and another cholesterol-fighting drug, Zocor, ranked fourth at $2.3 billion, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

21 Sep 2007

AHRQ and FDA to collaborate in ADHD study

Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.

21 Sep 2007